- GENFIT annonce de nouvelles données au congrès 2023 de l’European Association for the Study of the Liver (EASL)
- GENFIT Announces New Data at the European Association for the Study of the Liver (EASL) Congress 2023
- GENFIT Further Strengthens its ACLF Franchise with a Third Clinical-Stage Asset
- GENFIT renforce sa franchise ACLF avec un troisième composé de stade clinique
- GENFIT: May 24, 2023 Combined Shareholders Meeting results
- GENFIT : Résultats de l’Assemblée Générale Mixte du 24 mai 2023
- GENFIT Announces Publication of the Development and Validation of NIS2+™ in the Journal of Hepatology
- GENFIT annonce la publication présentant le développement et la validation de NIS2+™ dans le Journal of Hepatology
- GENFIT : Information financière du premier trimestre 2023
- GENFIT Reports First Quarter 2023 Financial Information
More ▼
Key statistics
As of last trade Genfit SA (GNFTF:PKL) traded at 3.80, -13.44% below its 52-week high of 4.39, set on May 09, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.00 |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 3.80 |
Average volume | 2.43k |
---|---|
Shares outstanding | 49.83m |
Free float | 43.25m |
P/E (TTM) | -- |
Market cap | 190.37m EUR |
EPS (TTM) | -0.4775 EUR |
Data delayed at least 15 minutes, as of Jun 07 2023.
More ▼